SKI Market

Indian Indices

Sensex

80,015.90 899.71
( 1.14%)

Global Indices

Nasdaq

48,766.17 243.89
(0.50%)

Dow Jones

6,891.51 53.88
(0.79%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,430.91 -136.74
(-1.29%)

Forex

USD-INR

91.96 0.48
(0.52%)

EUR-INR

106.94 -0.34
(-0.32%)

GBP-INR

122.70 0.09
(0.07%)

JPY-INR

0.58 0.00
(0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

65.01

167235.91

EPS(TTM)

Face Value()

Div & Yield %

96.91

0.48

Back

obcl ltd

Nath Industries standalone net profit rises 633.33% in the September 2025 quarter

Nov 16,2025

Net profit of Nath Industries rose 633.33% to Rs 4.40 crore in the quarter ended September 2025 as against Rs 0.60 crore during the previous quarter ended September 2024. Sales rose 31.93% to Rs 127.06 crore in the quarter ended September 2025 as against Rs 96.31 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	127.06	96.31	32
OPM %	5.31	5.03	-
PBDT	6.86	3.12	120
PBT	4.42	0.60	637
NP	4.40	0.60	633

80,015.90 899.71 ( 1.14%)

48,766.17 243.89 (0.50%)

6,891.51 53.88 (0.79%)

55,141.42 895.88 (1.65%)

10,430.91 -136.74 (-1.29%)

91.96 0.48 (0.52%)

106.94 -0.34 (-0.32%)

122.70 0.09 (0.07%)

0.58 0.00 (0.18%)